Economic Atlas
Companies/1CM Inc.
Company profile

1CM Inc.

OTC: MILFF · Healthcare · Drug Manufacturers - Specialty & Generic
Canadian filerHQ Markham, ONReports USD
#429 of 1,418 Healthcare companies by revenue69th-percentile growth
EA Score
70B
Revenue TTM
$54.7M
Rev growth YoY (TTM)
+8.6%
Net income (FY)
$347.0k
Employees
—
as of 2026-08-22
Market cap
$11.7M
as of 2026-08-22

Financials — latest annual

SEC EDGAR · USD-normalized
ConceptUSDNativeFY
Revenue$52.5M73.3M CAD2025
Net income$347.0k484.5k CAD2025
Operating income$1.2M1.6M CAD2025
Total assets$31.6M43.5M CAD2025
Liabilities$10.7M14.6M CAD2025
Equity$21.0M28.8M CAD2025

Revenue trend

FY2018 – FY2025 · USD
FY18
FY19
FY20
FY21
FY22
FY23
FY24
FY25

Revenue by segment

No segmentation disclosed for this filer. n/a

The read

What is 1CM Inc.’s revenue?

1CM Inc. booked $52.5M in FY2025 revenue, growing 25% year over year — faster than most Healthcare companies we track, at a 0.7% net margin.

Peers · Healthcare
Apyx Medical Corporation64CProtalix BioTherapeutics, Inc.66BIRIDEX Corporation55CONE Bio Corp.——Vext Science, Inc.64COcular Therapeutix, Inc.62C
Key facts
CEOTanvi Bhandari
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
HeadquartersMarkham, ON
ExchangeOTC: MILFF
Employees—
IPO date2018-07-20
Latest filings

No filings loaded — no CIK (non-SEC filer).

Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.